# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Bionano Genomics, Inc. (NASDAQ:BNGO), today announced the results of an implementation study conducted by researchers at Univer...
Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the publication of a study from Penn State College of Medicine that used o...
Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the publication of a study of optical genome mapping (OGM) in hereditary b...
Scotiabank analyst Sung Ji Nam maintains Bionano Genomics (NASDAQ:BNGO) with a Sector Outperform and lowers the price target...
2024 OutlookWe remain hyper focused on our mission of transforming the way the world sees the genome. To that end we want to hi...
Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $10.721 million which beat the analyst consensus estimate of $10.585...